Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,056 | 37,909 | 36,917 | 121,322 | 41,870 |
| Marketable Securities | 243,012 | 259,014 | 267,962 | 262,222 | 273,305 |
| Receivables | 3,539 | 4,127 | 1,048 | 858 | 1,826 |
| TOTAL | $291,909 | $310,294 | $319,388 | $394,375 | $331,540 |
| Non-Current Assets | |||||
| PPE Net | 64,384 | 82,392 | 87,534 | 92,116 | 96,836 |
| Investments And Advances | 27,657 | 33,607 | 47,162 | 7,595 | 980 |
| Other Non-Current Assets | 56,744 | 68,677 | 74,733 | 75,806 | 76,861 |
| TOTAL | $148,785 | $184,676 | $209,429 | $175,517 | $174,677 |
| Total Assets | $440,694 | $494,970 | $528,817 | $569,892 | $506,217 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,365 | 6,349 | 5,495 | 6,765 | 4,719 |
| Accrued Expenses | 21,348 | 23,580 | 22,654 | 32,043 | 27,514 |
| TOTAL | $38,522 | $37,422 | $34,793 | $45,369 | $39,094 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 393 | 600 | N/A | 159 | 685 |
| Other Non-Current Liabilities | 83,446 | 95,222 | 97,042 | 98,408 | 98,706 |
| TOTAL | $83,446 | $95,222 | $97,042 | $98,408 | $98,706 |
| Total Liabilities | $121,968 | $132,644 | $131,835 | $143,777 | $137,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 114,597 | 113,894 | 113,878 | 113,832 | 99,238 |
| Common Shares | 114 | 114 | 114 | 114 | 99 |
| Retained earnings | -1,397,994 | -1,345,841 | -1,298,163 | -1,259,736 | -1,211,732 |
| Other shareholders' equity | 271 | 838 | -419 | -191 | 18 |
| TOTAL | $318,726 | $362,326 | $396,982 | $426,115 | $368,417 |
| Total Liabilities And Equity | $440,694 | $494,970 | $528,817 | $569,892 | $506,217 |